<?xml version="1.0" encoding="UTF-8" ?>
<?xml-stylesheet type="text/xsl" href="https://blogs.mercola.com:443/utility/FeedStylesheets/rss.xsl" media="screen"?><rss version="2.0" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:slash="http://purl.org/rss/1.0/modules/slash/" xmlns:wfw="http://wellformedweb.org/CommentAPI/"><channel><xhtml:meta xmlns:xhtml="http://www.w3.org/1999/xhtml" name="robots" content="noindex" /><title>Off-Label Use For Thalidomide as a Cancer Drug Questioned</title><link>https://blogs.mercola.com:443/sites/vitalvotes/archive/2004/12/21/Off-Label-Use-For-Thalidomide-as-a-Cancer-Drug-Questioned.aspx</link><description>A month ago, I posted a blog item about the FDA strenghtening the "X classification" on accutane to prevent pregnant women from taking the drug, which can cause serious fetal abnormalities. The plan, slated to be activated next summer, mirrors a similar</description><dc:language>en</dc:language><generator>CommunityServer 2008.5 SP1 (Debug Build: 31106.3070)</generator></channel></rss>